Carbomer-modified spray-dried respirable powders for pulmonary delivery of salbutamol sulphate

Journal of Microencapsulation

Volumn 26, Issue 5, 2009, Pages 444-455

  Alhusban, Farhan A ^a   Seville, Peter C ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Carbomer; Inhalation; Leucine; Modified release; Salbutamol; Spray drying

Indexed keywords

CARBOMER; CARBOMER 971; CARBOPOL 974P; SALBUTAMOL SULFATE; UNCLASSIFIED DRUG;

AEROSOL; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRY POWDER; FEASIBILITY STUDY; SPRAY DRYING; SUSTAINED DRUG RELEASE;

ACRYLIC RESINS; ADMINISTRATION, INHALATION; AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; KINETICS; LEUCINE; LUNG; POWDERS;

EID: 70849132843     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802456924     Document Type: Article

References (37)

1. Asada M, Takahashi H, Okamoto H, Tanino H, Danjo K. 2004. Theophylline particle design using chitosan by the spray drying. Int J Pharm 270:167-174.
2. Buckton G, Chidavaenzi OC, Koosha F. 2002. The effect of spray-drying feed temperature and subsequent crystallization conditions on the physical form of lactose. AAPS PharmSciTech 3:E37.
3. Burjak M, Bogataj M, Velnar M, Grabnar I, Mrhar A. 2001. The study of drug release from microspheres adhered on pig vesical mucosa. Int J Pharm 224:123-130.
4. Chougule MB, Padhi BK, Jinturkar KA, Misra A. 2007. Development of dry powder inhalers. Recent Patents Drug Del Formulat 1:11-21.
5. Corrigan DO, Healy AM, Corrigan OI. 2006. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates. Eur J Pharm Biopharm 62:295-305.
6. Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben-Jebria A, Eskew ML, et al. 1997. Large porous particles for pulmonary drug delivery. Science 276:1868-1871. (Pubitemid 27443665)
7. Emami J, Hamishehkar H, Najafabadi AR, Gilani K, Minaiyan M, Mahdavi H, Mirzadeh H, Fakhari A, Nokhodchi A. 2008. Particle size design of PLGA microspheres for potential pulmonary drug delivery using response surface methodology. J Microencapsulation. DOI:10.1080/ 02652040802083900
8. Fajac I, Allo JC, Souil E, Merten M, Pichon C, Figarella C, et al. 2000. Histidylated polylysine as a synthetic vector for gene transfer into immortalized cystic fibrosis airway surface and airway gland serous cells. J Gene Med 2:368-378.
9. Fu J, Fiegel J, Krauland E, Hanes J. 2002. New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23:4425-4433.
10. Harikarnpakdee S, Lipipun V, Sutanthavibul N, Ritthidej GC. 2006. Spray-dried mucoadhesive microspheres: Preparation and transport through nasal cell monolayer. AAPS PharmSciTech 7:E12.
11. Koleng JJ, McGinity JW, Carbomer. 2000. In: Kibbe AH, editor. Handbook of pharmaceutical excipients, 3rd ed. London: Pharmaceutical Press. pp 79-82.
12. Kulvanich P, Leesawat P, Patomchaiviwat V. 2002. Release characteristics of the matrices prepared from co-spray-dried powders of theophylline and ethylcellulose. Drug Dev Ind Pharm 28:727-739.
13. Larhrib H, Martin GP, Marriott C, Prime D. 2003. The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm 257:283-296.
14. Learoyd TP. 2007. Controlled release in inhalation. PhD Thesis, Aston University, Birmingham, UK.
15. Learoyd TP, Burrows JL, French E, Seville PC. 2008a. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate. Eur J Pharm Biopharm 68:224-234.
16. Learoyd TP, Burrows JL, French E, Seville PC. 2008b. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Technol. DOI:10.1016/j.powtec.2008.02.015
17. Neau SH, Chow MY, Hileman GA, Durrani MJ, Gheyas F, Evans BA. 2000. Formulation and process considerations for beads containing Carbopol 974P, NF resin made by extrusion-spheronization. Int J Pharm 199:129-140.
18. Noveon. 2002. Controlled release tablets and capsules, Bulletin no. 17. Available online at: http://www.pharma.lubrizol.com/Bulletins/ epb17.pdf. Accessed 29/07/08.
19. Pringels E, Ameye D, Vervaet C, Foreman P, Remon JP. 2005. Starch/ Carbopol spray-dried mixtures as excipients for oral sustained drug delivery. J Contr Rel 103:635-641.
20. Rabbani NR, Seville PC. 2005. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Contr Rel 110:130-140.
21. Rao KR, Senapati P, Das MK. 2005. Formulation and in vitro evaluation of ethyl cellulose microspheres containing zidovudine. J Microencapsulation 22:863-876.
22. Sakagami M, Kinoshita W, Sakon K, Sato J, Makino Y. 2002. Mucoadhesive beclomethasone microspheres for powder inhalation: Their pharmacokinetics and pharmacodynamics evaluation. J Contr Rel 80:207-218.
23. Sakagami M, Sakon K, Kinoshita W, Makino Y. 2001. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Contr Rel 77:117-129.
24. Salama RO, Traini D, Chan HK, Young PM. 2008. Preparation and characterisation of controlled release co-spray dried drugpolymer microparticles for inhalation 2: Evaluation of in vitro release profiling methodologies for controlled release respiratory aerosols. Eur J Pharm Biopharm. DOI:10.1016/j.ejpb.2008.04.009
25. Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. 2004. In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 57:235-243.
26. Senel S, Capan Y, Hncal AA. 1991. Factors affecting the formulation of sustained release potassium chloride tablets. In: Rubenstein MH, Wells JI, editors. Pharmaceutical technology-controlled drug release. Vol.2, Chichester: Ellis Horwood. pp 33-42.
27. Seville PC, Learoyd TP, Li H-Y, Williamson IJ, Birchall JC. 2007a. Amino acid-modified spray-dried powders with enhanced aerosolisation properties for pulmonary drug delivery. Powder Technol 178:40-50.
28. Seville PC, Li HY, Learoyd TP. 2007b. Spray-dried powders for pulmonary drug delivery. Crit Rev Ther Drug Carrier Syst 24:307-360.
29. Shaw LR, Irwin WJ, Grattan TJ, Conway BR. 2002. The development of a modified dissolution method suitable for investigating powder mixtures. Drug Dev Ind Pharm 28:1147-1153.
30. Siepmann J, Peppas NA. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 48:139-157.
31. Singla AK, Chawla M, Singh A. 2000. Potential applications of carbomer in oral mucoadhesive controlled drug delivery system: A review. Drug Dev Ind Pharm 26:913-924.
32. Sivadas N, O'Rourke D, Tobin A, Buckley V, Ramtoola Z, Kelly JG, et al. 2008. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 358:159-167.
33. Surendrakumar K, Martyn GP, Hodgers EC, Jansen M, Blair JA. 2003. Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Contr Rel 91:385-394.
34. Taylor MK, Hickey AJ, VanOort M. 2006. Manufacture, characterization, and pharmacodynamic evaluation of engineered ipratropium bromide particles. Pharm Dev Technol 1:321-336.
35. Telko MJ, Hickey AJ. 2005. Dry powder inhaler formulation. Respir Care 50:1209-1227.
36. Ungaro F, De Rosa G, Miro A, Quaglia F, La Rotonda MI. 2006. Cyclodextrins in the production of large porous particles: Development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci 28:423-432.
37. Woolfson AD, McCafferty DF, McCarron PA, Price JH. 1995. Bioadhesive patch cervical drug delivery system for the administration of 5-fluorouracil to cervical tissue. J Contr Rel 35:49-58.